Prognostic Value of Specific High-Risk Cytogenetic Abnormalities and Ethnicity in Outcomes after Autologous Stem Cell Transplant in Multiple Myeloma

被引：0
|
作者：
Basher, Fahmin [1 ,2 ]
Sanchez, Sandra [3 ]
Hoffman, James E. [4 ]
Lekakis, Lazaros J. [4 ]
Pereira, Denise [5 ]
机构：
[1] Duke Univ, Med Ctr, Dept Med, Miami, FL USA
[2] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Pathol & Lab Med, Div Hematopathol, Miami, FL USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[5] Univ Miami, Sylvester Comprehens Canc Ctr, Div Transplantat & Cellular Therapy, Miami, FL USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-154303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5041
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Using genomics to identify high-risk myeloma after autologous stem cell transplantation
    Shaughnessy, JD
    Barlogie, B
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) : 77 - 80
  • [32] Is There an Unequal Benefit of Autologous Stem Cell Transplant in Different Cytogenetic Groups of High Risk Patients with Multiple Myeloma: The University of Miami Experience
    Basher, Fahmin
    Sanchez, Sandra
    Schatz, Jonathan H.
    Hoffman, James E.
    Lekakis, Lazaros J.
    BLOOD, 2020, 136
  • [33] Outcomes of Bortezomib Maintenance Compared with Lenalidomide Maintenance in Patients with High-Risk Multiple Myeloma and Chronic Kidney Disease Undergoing Autologous Stem Cell Transplant
    Nangia, Udit
    Chandramohan, Deepak
    Garapati, Hari Naga
    Simhadri, Prathap
    Mahajan, Neeraj
    BLOOD, 2024, 144 : 4754 - 4754
  • [34] OUTCOMES FOLLOWING SALVAGE AUTOLOGOUS STEM CELL TRANSPLANT (SCT) FOR MULTIPLE MYELOMA
    Rondo, Silva C.
    Hassoun, H.
    Chimento, D.
    Jia, X.
    Giralt, S.
    Landau, H. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S254 - S254
  • [35] High risk cytogenetic abnormalities in patients with multiple myeloma
    Eugenia Legues, Maria
    Morales, Paulina
    Valenzuela, Mercedes
    Encina, Andrea
    Jose Marti, Maria
    Bascunan, Claudia
    Cornejo, Paulina
    Pena, Camila
    Soledad Undurraga, Maria
    REVISTA MEDICA DE CHILE, 2019, 147 (01) : 61 - 64
  • [36] Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma
    Davis, James A.
    Thurlapati, Aswani
    Weeda, Erin
    Gaffney, Kelly J.
    Smith, Deidra
    Maldonado, Andy
    Granger, Katelynn
    Martin, Kristy E.
    Williams, Yolanda M.
    Herrington, Taylor
    Velayati, Arash
    Bakos, Jonathan K.
    Green, Kimberly
    Hashmi, Hamza
    ANNALS OF HEMATOLOGY, 2024, 103 (01) : 251 - 258
  • [37] Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma
    James A. Davis
    Aswani Thurlapati
    Erin Weeda
    Kelly J. Gaffney
    Deidra Smith
    Andy Maldonado
    Katelynn Granger
    Kristy E. Martin
    Yolanda M. Williams
    Taylor Herrington
    Arash Velayati
    Jonathan K. Bakos
    Kimberly Green
    Hamza Hashmi
    Annals of Hematology, 2024, 103 : 251 - 258
  • [38] Incorporating cytogenetic features into prognostic scoring at point of autologous stem cell transplantation for multiple myeloma
    Klammer, M.
    Giles, C.
    Reid, A.
    Ross, F.
    Szydlo, R.
    Gabriel, I.
    Samson, D.
    Apperley, J.
    Rahemtulla, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S181 - S181
  • [39] Cumulative effect of cytogenetic hits on multiple myeloma relapse after front-line autologous stem cell transplant
    Baptista, P.
    Henriques, M.
    Pardal, A. A.
    Monteiro, P.
    Chorao, P.
    Soares, M. J.
    Barbosa, A.
    Gomes, P.
    Bergantim, R.
    Aguiar, E.
    Pires, J. C.
    Trigo, F.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 322 - 322
  • [40] Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma
    Pasvolsky, Oren
    Milton, Denai R.
    Rauf, Mikael
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Tang, Guilin
    Saini, Neeraj
    Ramdial, Jeremy
    Masood, Adeel
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (11): : 752.e1 - 752.e6
12345